Literature DB >> 20617559

TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts.

Lars Mueller1, Lena von Seggern, Jennifer Schumacher, Freya Goumas, Christian Wilms, Felix Braun, Dieter C Broering.   

Abstract

Cancer-associated fibroblasts (CAFs) represent the predominant cell type of the neoplastic stroma of solid tumors, yet their biology and functional specificity for cancer pathogenesis remain unclear. We show here that primary CAFs from colorectal liver metastases express several inflammatory, tumor-enhancing factors, including interleukin (IL)-6 and monocyte-chemoattractant protein (MCP)-1. Both molecules were intensely induced by TNF-alpha on the transcript and protein level, whereas PDGF-BB, TGF-beta1 and EGF showed no significant effects. To verify their potential specialization for metastasis progression, CAFs were compared to fibroblasts from non-tumor liver tissue. Interestingly, these liver fibroblasts (LFs) displayed similar functions. Further analyses revealed a comparable up-regulation of intercellular adhesion molecule-1 (ICAM-1) by TNF-alpha, and of alpha-smooth muscle actin, by TGF-beta1. Moreover, the proliferation of both cell types was induced by PDGF-BB, and CAFs and LFs displayed an equivalent migration towards HT29 colon cancer cells in Boyden chamber assays. In conclusion, colorectal liver metastasis may be supported by CAFs and resident fibroblastic cells competent to generate a prometastatic microenvironment through inflammatory activation of IL-6 and MCP-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617559     DOI: 10.1016/j.bbrc.2010.05.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

2.  Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.

Authors:  David Bauer; Elizabeth Mazzio; Karam Fa Soliman; Equar Taka; Ebenezer Oriaku; Tracey Womble; Selina Darling-Reed
Journal:  Anticancer Res       Date:  2014-06       Impact factor: 2.480

Review 3.  Targeting tumor cell motility to prevent metastasis.

Authors:  Trenis D Palmer; William J Ashby; John D Lewis; Andries Zijlstra
Journal:  Adv Drug Deliv Rev       Date:  2011-06-02       Impact factor: 15.470

4.  Promising Effects of Zerumbone on the Regulation of Tumor-promoting Cytokines Induced by TNF-α-activated Fibroblasts.

Authors:  Zahra Radaei; Alireza Zamani; Rezvan Najafi; Massoud Saidijam; Farid Azizi Jalilian; Razieh Ezati; Ghasem Solgi; Razieh Amini
Journal:  Curr Med Sci       Date:  2021-01-11

5.  CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.

Authors:  Yuan Liu; Elianna B Amin; Marty W Mayo; Neel P Chudgar; Peter R Bucciarelli; Kyuichi Kadota; Prasad S Adusumilli; David R Jones
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

6.  CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice.

Authors:  Marta Pevida; Sara González-Rodríguez; Ana Lastra; Agustín Hidalgo; Luis Menéndez; Ana Baamonde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-09-14       Impact factor: 3.000

7.  Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease?

Authors:  Ian A Clark; Craig S Atwood
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 8.  Tumor stroma as targets for cancer therapy.

Authors:  Jing Zhang; Jinsong Liu
Journal:  Pharmacol Ther       Date:  2012-10-12       Impact factor: 12.310

9.  PPM1A is a RelA phosphatase with tumor suppressor-like activity.

Authors:  X Lu; H An; R Jin; M Zou; Y Guo; P-F Su; D Liu; Y Shyr; W G Yarbrough
Journal:  Oncogene       Date:  2013-07-01       Impact factor: 9.867

10.  Inhibition of MK2 suppresses IL-1β, IL-6, and TNF-α-dependent colorectal cancer growth.

Authors:  Anita L Ray; Kiersten L Berggren; Sebastian Restrepo Cruz; Gregory N Gan; Ellen J Beswick
Journal:  Int J Cancer       Date:  2017-12-12       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.